Advertisement

Rheumatology International

, Volume 16, Issue 6, pp 237–240 | Cite as

Type II collagen serology: a guide to clinical responsiveness to oral tolerance?

  • U. Gimsa
  • N. A. Mitchison
  • J. Sieper
  • J. Braun
Original Article

Abstract

A double-blind placebo-controlled randomized trial of oral collagen type II (CII) treatment in rheumatoid arthritis was completed in Berlin. Anti-CII antibody titres were measured before and after the treatment. They showed that: (1) the titre prior to treatment did not identify a responder subgroup, (2) the treatment reduced CII antibody titres, but only in those patients making a clinical response and (3) administration of 10 mg CII per day reduced the titre in these subsets more effectively than 1 mg per day. Although the data are limited, they suggest that a titre drop may be useful for identifying those patients who respond to this form of treatment and that the drop may be a valid parameter for detecting the impact of the treatment on the immune system.

Key words

Collagen II Rheumatoid arthritis Antibodies Oral tolerance 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Sieper J, Kary S, Sörensen H, Alten R, Eggens U, Hüge W, Hiepe F, Kühne A, Listing J, Ullbrich N, Braun J, Zink A, Mitchison NA (1996) Oral collagen II treatment in early rheumatoid arthritis: a double-blind placebo-controlled randomized trial. Arthritis Rheum 39:41–51PubMedGoogle Scholar
  2. 2.
    Felson D (1994) ACR committee on outcome measures in RA trials: American College of Rheumatology (ACR) preliminary criteria for improvement in rheumatoid arthritis (RA) trials. Arthritis Rheum 37:S195Google Scholar
  3. 3.
    Trentham DE, Dynesius-Trentham RA, Orav EJ, Combitchi D, Lorenzo C, Sewell KL, Hafler DA, Weiner HL (1993) Effects of oral administration of type 11 collagen. Science 261:1727–1730PubMedGoogle Scholar
  4. 4.
    Nagler-Anderson C, Bober LA, Robinson ME, Siskind GW, Thorbecke FJ (1986) Suppression of type II collagen-induced arthritis by intragastric administration of soluble type Il collagen. Proc Natl Acad Sci USA 83:7443–7446PubMedGoogle Scholar
  5. 5.
    Thompson HSG, Staines NA (1986) Gastric administration of type II collagen delays the onset and severity of collageninduced arthritis in rats. Clin Exp Immunol 64:581–586PubMedGoogle Scholar
  6. 6.
    Zhang JZ, Lee CSY, Lider O, Weiner HL (1988) Suppression of adjuvant arthritis in Lewis rats by oral administration of type II collagen. J Immunol 145:2489–2493Google Scholar
  7. 7.
    Khare SD, Krco CJ, Griffiths MM, Luthra HS, David CS (1995) Oral administration of an immunodominant human collagen peptide modulates collagen-induced arthritis. J Immunol 155:3653–3659PubMedGoogle Scholar
  8. 8.
    Nussenblatt RB, Whitcup SM, de Smet MD, Caspi RR, Kozhich AT, Weiner HL, Vistica B, Gery I (1996) Intraocular inflammatory disease (uveitis) and the use of oral tolerance: a status report. Ann NY Acad Sci 778:325–337PubMedGoogle Scholar
  9. 9.
    Whitacre CC, Gienapp IE, Meyer A, Cox KL, Javed N (1996) Oral tolerance in experimental autoimmune encephalomyelitis. Ann NY Acad Sci 778:217–227PubMedGoogle Scholar
  10. 10.
    Staines NA, Harper N (1995) Oral tolerance in the control of experimental models of autoimmune disease. Z Rheumatol 54:145–154PubMedGoogle Scholar
  11. 11.
    Weiner HL, Friedman A, Miller A, Khoury SJ, al-Sabbagh A, Santos L, Sayegh M, Nussenblatt RB, Trentham DE, Hafler DA (1994) Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu Rev Immunol 12:809–837PubMedGoogle Scholar
  12. 12.
    Dick AD, Cheng YF, McKinnon A, Liversidge J, Forrester JV (1993) Nasal administration of retinal antigens suppresses the inflammatory response in experimental allergic uveoretinitis. A preliminary report of intranasal induction of tolerance with retinal antigens. Br J Ophthalmol 77:171–175PubMedGoogle Scholar
  13. 13.
    Miller EJ, Rhodes RK (1982) Preparation and characterization of the different types of collagen. Methods Enzymol 82:33–64PubMedGoogle Scholar
  14. 14.
    Dietrich A, Mitchison NA, Raijnavölgyi E, Schneider S (1994) Primed lymphocytes are boosted by type II collagen of their hosts after adoptive transfer. J Autoimmun 7:601–609PubMedGoogle Scholar
  15. 15.
    Boissier MC, Chiocchia G, Ronziere MC, Herbage D, Fournier C (1990) Arthritogenicity of minot cartilage collagens (types IX and XI) in mice. Arthritis Rheum 33:1–8PubMedGoogle Scholar
  16. 16.
    Schuppan D, Rühlmann T, Hahn EG (1985) Radioimmunoassay for human type VI collagen and its application to tissue and body fluids. Anal Biochem 149:238–247PubMedGoogle Scholar
  17. 17.
    Schuppan D, Besser M, Schwarting R, Hahn EG (1986) Radioimmunoassay for the carboxy-terminal cross-linking domain of type IV (basement membrane) procollagen in body fluids. Char acterization and application to collagen type IV metabolism in fibrotic liver disease. J Clin Invest 78:241–248PubMedGoogle Scholar
  18. 18.
    Becker J, Schuppan D, Benzian H, Bals T, Hahn EG, Cantaluppi C, Reichart P (1986) lmmunohistochemical distribution of collagens IV, V and VI and of pro-collagens types I and III in human alveolar bone and dentine. J Histochem Cytochem 34:1417–1429PubMedGoogle Scholar
  19. 19.
    Mitchison NA (1996) Adoptive transfer. In: Weir DM, Herzenberg LA, Blackwell LA, Blackwell C, Herzenberg LA (eds) Handbook of experimental immunology. Blackwell Science Inc., Cambridge, Mass. (in press)Google Scholar
  20. 20.
    Charriere G, Hartmann DJ, Vignon E, Ronziere M-C, Herbage D, Ville G (1988) Antibodies to types I, II, IX, and XI collagen in the serum of patients with rheumatic diseases. Arthritis Rheum 31:325–332PubMedGoogle Scholar
  21. 21.
    Rowley M, Tait B, Mackay IR, Cunningham T, Phillips B (1986) Collagen antibodies to denatured collagen and their association with HLA-DR4. Arthritis Rheum 29:174–184PubMedGoogle Scholar
  22. 22.
    Rönnelid J, Lysholm J, Engström-Lauren A, Klareskog L, Heyman B (1994) Local anti-type II collagen antibody production in rheumatoid arthritis synovial fluid. Arthritis Rheum 37:1023–1029PubMedGoogle Scholar
  23. 23.
    Dyer PA, Clague RB, Klouda PT, Firth S, Harris R, Holt PJL (1982) HLA antigens in patients with rheumatoid arthritis and antibodies to native type II collagen. Tissue Antigens 20:394–396PubMedGoogle Scholar
  24. 24.
    Collier DH, Kerwar SS, Garovoy MR, Fye KH, Stobo JD (1984) Anticollagen antibodies and immune response gene products in rheumatoid arthritis. Arthritis Rheum 27:1201–1209PubMedGoogle Scholar
  25. 25.
    Klimiuk PS, Clague RB, Grennan DM, Dyer PA, Smeaton I, Harris R (1985) Autoimmunity to native type II collagen — a distinct genetic subset of rheumatoid arthritis. J Rheumatol 12:865–870PubMedGoogle Scholar
  26. 26.
    Beard HK, Ryvar R, Skingle J, Greenbury CL (1980) Anticollagen antibodies in sera from rheumatoid arthritis patients. J Clin Pathol 33:1077–1081PubMedGoogle Scholar
  27. 27.
    Morgan K, Clague RB, Reynolds I, Davis M (1993) Antibodies to type II collagen in early rheumatoid arthritis. J Rheumatol 32:333–335Google Scholar
  28. 28.
    Bloch K, Bloch D, Stearns M, Walker WA (1977) Intestinal uptake of macromolecules. VI. Uptake of protein antigen in vivo in normal rats and in rats infected withNippostrongylus brasiliensis or subjected to mild systemic anaphylaxis. Gastroenterology 77:1039–1044Google Scholar
  29. 29.
    Hanson D, Roy M, Green GM, Miller S (1993) Inhibition of orally-induced immune tolerance in mice by prefeeding an endopeptidase inhibitor. Reg Immunol 5:74–76Google Scholar
  30. 30.
    Bjarnason I, Williams P, So A, Zanelli GD, Levi AJ, Gumpel JM, Peters TJ, Ansell B (1984) Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal antiinflammatory drugs. Lancet 11:1171–1173Google Scholar
  31. 31.
    Bjarnason I, Zanelli G, Smith T, Prouse P, Williams P, Smethurst P, Delacey G, Gumpel MJ, Levi AJ (1987) Non-steroidal antiinflammatory drug-induced intestinal inflammation in humans. Gastroenterology 93:1070–1074Google Scholar
  32. 32.
    Michaeli D, Fudenberg HH (1974) The incidence and antigenic specificity of antibodies against denatured human collagen in rheumatoid arthritis. Clin Immunol Immunopathol 2:153–159PubMedGoogle Scholar
  33. 33.
    Ferriss J, Cooper S, Roessner K, Hochberg M (1990) Antibodies to denatured type II collagen in rheumatoid arthritis: negative association with IgM rheumatoid factor. J Rheumatol 17:880–884PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1997

Authors and Affiliations

  • U. Gimsa
    • 1
  • N. A. Mitchison
    • 1
  • J. Sieper
    • 2
  • J. Braun
    • 2
  1. 1.Deutsches Rheuma-Forschungs-Zentrum BerlinBerlinGermany
  2. 2.Department of Medicine, RheumatologyKlinikum Benjamin FranklinBerlinGermany

Personalised recommendations